![]() |
Volumn 12, Issue 8, 2006, Pages 890-891
|
Side effects may include evolution
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
ANTIBIOTIC AGENT;
BETA LACTAMASE;
COMPETENCE STIMULATING PHEROMONE;
DNA;
DNA BINDING PROTEIN;
DNA TOPOISOMERASE;
LUCIFERASE;
MITOMYCIN C;
PHEROMONE;
PROTEIN HISTIDINE KINASE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RECA PROTEIN;
SIGMA FACTOR;
SSBB PROTEIN;
UNCLASSIFIED DRUG;
VIRULENCE FACTOR;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
BACTERIUM COMPETENCE;
DNA DAMAGE;
EVOLUTION;
GENE EXPRESSION;
GENE MUTATION;
GENETIC RECOMBINATION;
GENETIC VARIABILITY;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
REPRESSOR GENE;
SHORT SURVEY;
STREPTOCOCCUS PNEUMONIAE;
SUPPRESSOR GENE;
TRANSPOSON;
ANTI-BACTERIAL AGENTS;
CHROMOSOMES, BACTERIAL;
DNA;
DRUG RESISTANCE, MICROBIAL;
EVOLUTION, MOLECULAR;
GENES, BACTERIAL;
MODELS, GENETIC;
RECOMBINATION, GENETIC;
STREPTOCOCCUS PNEUMONIAE;
TRANSFORMATION, GENETIC;
|
EID: 33746824955
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0806-890 Document Type: Short Survey |
Times cited : (10)
|
References (15)
|